Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PEARQ | Class B Common Stock | Conversion of derivative security | -6.54M | -100% | 0 | Dec 3, 2021 | Common Stock | Direct | F1 | ||||
transaction | PEARQ | Private Placement Warrants | Other | $7.52M | +5.01M | $1.50* | 5.01M | Dec 3, 2021 | Common Stock | 5.01M | $11.50 | Direct | F2 |
Lj10 Llc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | In connection with the consummation of the business combination between Thimble Point Acquisition Corp. ("THMA" and the former name of the Issuer) and Pear Therapeutics, Inc. on December 3, 2021 (the "Closing Date"), the Reporting Person's shares of THMA Class B Common Stock were automatically converted into shares of the Issuer's Common Stock on a one-for-one basis. |
F2 | The private placement warrants were purchased by the Reporting Person in connection with THMA's initial public offering on February 1, 2021. Each private placement warrant is exercisable to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment, beginning on February 4, 2022 and expires on December 3, 2026 or earlier upon redemption or liquidation. |
On the Closing Date, the Reporting Person ceased to own more than 10% of a class of the Issuer's equity securities.